MONOVISC® INJECTION, 4ML
$349.00
Monovisc injection is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
Manufacturer: Anika Therapeutics
Strength: 22mg/ml
Pack Size: 1 X 4ml Pre-Filled Syringe
Additional information
Monovisc is a next-generation viscosupplement manufactured by Anika Therapeutics, specifically formulated to treat the symptoms of osteoarthritis in the knee. Utilizing high molecular weight hyaluronic acid, Monovisc offers patients a non-surgical option for managing joint pain. Its unique formulation provides lubrication and cushioning to the joint, improving movement and reducing discomfort. This single-injection treatment is ideal for patients seeking an effective, minimally invasive solution to knee osteoarthritis.
Indication and Applications
Monovisc is indicated for the treatment of pain in osteoarthritis of the knee in patients who have not responded adequately to conservative non-pharmacologic therapy or simple analgesics like acetaminophen.
Main Treatment Areas:
- Knee Joint: Provides significant pain relief and improves mobility, reducing stiffness and discomfort.
Injection Key Benefits:
- Convenient single injection treatment
- Highly concentrated, non-animal sourced HA
- Long lasting relief through 26 weeks
- Convenience of a single injection as opposed to multiple visits to the physician
- No confirmed pseudoseptic reactions reported
Ingredients:
- Sodium Hyaluronate: A naturally occurring substance that provides lubrication and cushioning to the joints. Monovisc’s hyaluronic acid is highly purified and non-animal-derived.
MONOVISC Price Information
Monovisc is available for purchase through Dr Sales Direct, a trusted wholesale supplier. Each injection (4mL) is priced at $349, with bulk discounts available: $339 each for 6-10 units (2.87% discount), $334 each for 11-20 units (4.3% discount), and $329 each for 21 or more units (5.73% discount). Take advantage of competitive wholesale prices and reliable supply to meet your clinical needs.
We offer fast, reliable, and secure service at wholesale discount pricing. Contact us now.
Frequently Asked Questions
Monovisc injections can provide effective pain relief for knee osteoarthritis for up to six months. The duration may vary depending on individual patient factors.
Monovisc contains a high molecular weight, ultra-pure form of hyaluronic acid derived from bacterial cells. It is a viscosupplement designed to mimic the natural hyaluronic acid found in healthy joints.
After a Monovisc injection, patients may experience pain relief starting within two weeks, with effects lasting up to six months. There may be temporary pain or swelling at the injection site, which should subside within a few days.
Monovisc is effective in reducing pain and improving joint function in patients with knee osteoarthritis. Clinical studies have shown significant improvements in pain scores and joint mobility for many patients.
Monovisc is typically administered as a single injection, which makes it convenient compared to other hyaluronic acid treatments that may require multiple injections.
Monovisc and Synvisc both provide effective pain relief for knee osteoarthritis, but they differ in their composition and administration. Monovisc is a single injection of high molecular weight hyaluronic acid, whereas Synvisc can be administered as either three weekly injections or a single large dose (Synvisc-One). The choice between them depends on patient preference and response to treatment.